Stock Quote
Altair Nanotechnologies Inc (ALTI.W) (NASD ADF)
$0.95
18 Nov 2009
-3.46%
$0.98
$0.95
7,100
$0.95
$0.95
$1.55
$0.60
1.70
310,765
ALTI.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Bengtson, Jon | Chairman of the Board | -- |
| Copeland, Terry | President, Chief Executive Officer, Director | 600,346 |
| Fallini, John | Chief Financial Officer, Secretary | 339,470 |
Profile
Altair Nanotechnologies Inc. is a Canadian corporation, whose primary business is developing and commercializing nanomaterial and titanium dioxide pigment technologies. The Company organized in three divisions, a Power and Energy Group (formally known as the Advanced Materials and Power Systems... Full Description
Company Address
Altair Nanotechnologies Inc
204 Edison Way
Reno NV 89502
P: +1775.8562500
204 Edison Way
Reno NV 89502
P: +1775.8562500
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| GlaxoSmithKline plc | £1,265.50 | -12.00 |
| Genzyme Corporation | $50.24 | +0.19 |
| Fresenius Medical Care AG & Co. KGaA | €35.93 | +0.15 |
| ALTI.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 1.06 |
| P/S(TTM) | 27.89 | 0.07 |
| ROI(TTM) | -49.07 | 0.29 |
| ROE(TTM) | -48.88 | 0.48 |
| Consensus Recommendation | Underperform |
|---|---|
| EPS Est. (Current Period) | -0.05 |
| EPS Est. (Current Year) | -0.22 |
| Total Revenue | $1.67M |
| Net Income | $-3.39M |
| EPS | $-0.03 |
